The European Patent Office (EPO) issued patent EP2807979 B1 entitled “Detection device for in-vivo and/or in-vitro enrichment of sample material”. The patent describes a functionalized structured medical wire for the enrichment of sample material. The technology is already being used in clinical settings on national and international levels.
”With the issuance of this new European Patent we are further strengthening GILUPI’s superior intellectual property position in the area of CTC enrichment. The commercialization of this IP is already ongoing and we will continue to leverage our IP with new products that are currently in development.” said Dr. Christian Jurinke, CEO of GILUPI.
GILUPI´s patent portfolio consists of 11 patent families and further patent applications that are currently subject to examination procedures for a number of inventions.
GILUPI GmbH
Hermannswerder 20a
14473 Potsdam
Telefon: +49 (331) 5818478-2
Telefax: +49 (331) 5818478-0
http://www.gilupi.com
Marketing & Sales Application Specialist
Telefon: +49 (331) 5818478-5
E-Mail: info@gilupi.com